TransAct Technologies Incorporated (NASDAQ:TACT) shares moved up 0.30% in last trading session and ended the day at $10.02. TACT Gross Margin is 40.40% and its has a return on assets of -3.90%. TransAct Technologies Incorporated (NASDAQ:TACT) quarterly performance is 40.61%.
TransAct Technologies Incorporated (NASDAQ: TACT) announced an agreement with Aristocrat Technologies Inc. (“Aristocrat”) to integrate the capabilities of TransAct’s Epicentral® voucher-based promotions software system with Aristocrat’s Oasis 360™ advanced casino management system. As part of the agreement, both companies will market the voucher-based management system to the Oasis 360™ customer base to support promotions distribution within the Oasis Brand Connectivity solution. TransAct (Booth #2423) and Aristocrat (Booth #1141) will both demonstrate the benefits of this partnership for casinos at the 15th annual Global Gaming Expo (G2E®) to be held at the Sands Expo & Convention Center from September 29-October 1, 2015 in Las Vegas.
Olin Corp. (NYSE:OLN) ended the last trading day at $17.67. Company weekly volatility is calculated as 4.50% and price to cash ratio as 6.32. Olin Corp. (NYSE:OLN) showed a weekly performance of 5.12%.
Effective September 29, 2015, Olin Corporation’s (NYSE:OLN) Benefit Plan Review Committee amended and restated the Olin Corporation Supplemental Contributing Employee Ownership Plan (“SCEOP”). The SCEOP was amended in connection with the previously announced acquisition of the Dow Chlorine Products business of The Dow Chemical Company (“TDCC”) by the Company (the “Merger”).
On 07 October, Impac Mortgage Holdings Inc. (NYSEMKT:IMH) shares moved up 4.71% and was closed at $19.13. IMH EPS growth in last 5 year was -38.00%. Impac Mortgage Holdings Inc. (NYSEMKT:IMH) year to date (YTD) performance is 208.55%.
Lantheus Holdings, Inc. (NASDAQ:LNTH) shares moved up 6.23% in last trading session and ended the day at $3.75. LNTH Gross Margin is 44.10% and its has a return on assets of -10.00%. Lantheus Holdings, Inc. (NASDAQ:LNTH) quarterly performance is -46.43%.
Lantheus Holdings (NASDAQ:LNTH) was downgraded by Zacks from a “hold” rating to a “sell” rating in a report issued on Wednesday, Analyst Ratings.Net reports.
Incyte Corporation (NASDAQ:INCY) caters to the Healthcare space. It has a net profit margin of 2.10% and weekly performance is -1.52%. On the last day of trading company shares ended up at $108.65. Incyte Corporation (NASDAQ:INCY) distance from 50-day simple moving average (SMA50) is -3.88%.
On 29 September, Eli Lilly and Company (LLY) and Incyte Corporation (NASDAQ:INCY) announced positive top-line results of RA-BEGIN, the third Phase 3 study evaluating the safety and efficacy of baricitinib, an investigational medicine for patients with moderately-to-severely active rheumatoid arthritis (RA). The study met its primary objective of demonstrating non-inferiority of baricitinib monotherapy to methotrexate monotherapy based on ACR20 response rate after 24 weeks of treatment. Additionally, baricitinib was superior to methotrexate based on ACR20 response.
Leave a Reply